年単位の研究成果
Fingerprint Fingerprintは、論文等の研究業績を自然後処理することで作成された、重み付けキーワード群です。研究者や組織の主要な研究内容を表します。
- 38 同様のプロファイル
Hematopoietic Stem Cells
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
Stem Cells
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Myeloid Progenitor Cells
Medicine & Life Sciences
Stem cells
Chemical Compounds
Therapeutics
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 1988 2019
2
引用
(Scopus)
A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma
on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), 1 22 2019, ： : International journal of hematology. 109, 1, p. 107-114 8 p.研究成果: ジャーナルへの寄稿 › 記事
Multiple Myeloma
Peripheral Blood Stem Cell Transplantation
Dexamethasone
Therapeutics
lenalidomide
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., 1 1 2019, ： : International Journal of Clinical Oncology.研究成果: ジャーナルへの寄稿 › 記事
Cell Transplantation
Stem Cell Transplantation
Group Psychotherapy
Cell- and Tissue-Based Therapy
Multiple Myeloma
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: A post hoc analysis of a phase I/II clinical trial conducted in Japan
Ayano, M., Tsukamoto, H., Mitoma, H., kimoto, Y., Akahoshi, M., Arinobu, Y., Miyamoto, T., Horiuchi, T., Niiro, H., Nagafuji, K., Harada, M. & Akashi, K., 1 22 2019, ： : Arthritis Research and Therapy. 21, 1, 30.研究成果: ジャーナルへの寄稿 › 記事
Phase II Clinical Trials
Clinical Trials, Phase I
Systemic Scleroderma
Hematopoietic Stem Cell Transplantation
Japan
Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma
Shimono, J., Miyoshi, H., Arakawa, F., Yamada, K., Sugio, T., Miyawaki, K., Eto, T., Miyagishima, T., Kato, K., Nagafuji, K., Akashi, K., Teshima, T. & Ohshima, K., 5 1 2019, ： : Annals of Hematology. 98, 5, p. 1197-1207 11 p.研究成果: ジャーナルへの寄稿 › 記事
Lymphoma, Large B-Cell, Diffuse
Hepacivirus
B-Cell Lymphoma
RNA
Reverse Transcription
Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma (International Journal of Hematology, (2019), 109, 1, (107-114), 10.1007/s12185-018-2543-y)
on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), 1 22 2019, ： : International journal of hematology. 109, 1, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Hematology
Multiple Myeloma
Fees and Charges
Pharmaceutical Preparations
Organized Financing